Contact this trialFirst, we need to learn more about you.
Virus Therapy
INO-3107 for Respiratory Papillomatosis
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial is testing a new drug to treat people with HPV-6 and/or HPV-11-associated recurrent respiratory papillomatosis (RRP). The trial population will include participants who have been diagnosed with either Juvenile-Onset RRP (J-O RRP) or with Adult- Onset RRP (A-O RRP). A safety run-in will be performed with up to six participants with a one week waiting period between each enrolled participant.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.